Extended experience with glycine for prevention of reperfusion injury after human liver transplantation

Transplant Proc. 2002 Sep;34(6):2307-9. doi: 10.1016/s0041-1345(02)03247-5.

Authors

P Schemmer¹, M Golling, T Kraus, A Mehrabi, E Mayatepek, Ch Herfarth, E Klar

Affiliation

¹ Department of Surgery and the Childrens Hospital, Division of Metabolic and Endocrine Disease, Ruprecht-Karls-University of Heidelberg, Heidelberg, Germany.

PMID: 12270410
DOI: 10.1016/s0041-1345(02)03247-5

No abstract available

MeSH terms

Adenosine
Adult
Alanine Transaminase / blood
Allopurinol
Aspartate Aminotransferases / blood
Brain Death
Glutathione
Glycine / administration & dosage
Glycine / therapeutic use*
Hepatectomy / methods
Humans
Infusions, Intravenous
Insulin
Liver Function Tests
Liver Transplantation / methods*
Liver Transplantation / physiology
Liver*
Organ Preservation / methods*
Organ Preservation Solutions
Raffinose
Reperfusion Injury / prevention & control*
Tissue Donors
Tissue and Organ Harvesting / methods

Substances

Insulin
Organ Preservation Solutions
University of Wisconsin-lactobionate solution
Allopurinol
Aspartate Aminotransferases
Alanine Transaminase
Glutathione
Adenosine
Raffinose
Glycine